Belite Bio, Inc. (BLTE)
159.93
-0.89
(-0.55%)
USD |
NASDAQ |
Dec 31, 09:41
Belite Bio Market Cap: 6.000B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ocugen, Inc. | 429.44M |
| Ionis Pharmaceuticals, Inc. | 12.80B |
| Ligand Pharmaceuticals, Inc. | 3.721B |
| IDEAYA Biosciences, Inc. | 3.025B |
| Terns Pharmaceuticals, Inc. | 3.669B |
Market Cap Related Metrics
| PEG Ratio | -1.137 |
| Price to Book Value | 21.89 |
| Price | 159.93 |
| Earnings Yield | -1.20% |
| PEGY Ratio | -1.137 |